Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

نویسندگان

  • Antonis C Antoniou
  • Olga M Sinilnikova
  • Lesley McGuffog
  • Sue Healey
  • Heli Nevanlinna
  • Tuomas Heikkinen
  • Jacques Simard
  • Amanda B Spurdle
  • Jonathan Beesley
  • Xiaoqing Chen
  • Susan L Neuhausen
  • Yuan C Ding
  • Fergus J Couch
  • Xianshu Wang
  • Zachary Fredericksen
  • Paolo Peterlongo
  • Bernard Peissel
  • Bernardo Bonanni
  • Alessandra Viel
  • Loris Bernard
  • Paolo Radice
  • Csilla I Szabo
  • Lenka Foretova
  • Michal Zikan
  • Kathleen Claes
  • Mark H Greene
  • Phuong L Mai
  • Gad Rennert
  • Flavio Lejbkowicz
  • Irene L Andrulis
  • Hilmi Ozcelik
  • Gord Glendon
  • Anne-Marie Gerdes
  • Mads Thomassen
  • Lone Sunde
  • Maria A Caligo
  • Yael Laitman
  • Tair Kontorovich
  • Shimrit Cohen
  • Bella Kaufman
  • Efrat Dagan
  • Ruth Gershoni Baruch
  • Eitan Friedman
  • Katja Harbst
  • Gisela Barbany-Bustinza
  • Johanna Rantala
  • Hans Ehrencrona
  • Per Karlsson
  • Susan M Domchek
  • Katherine L Nathanson
  • Ana Osorio
  • Ignacio Blanco
  • Adriana Lasa
  • Javier Benítez
  • Ute Hamann
  • Frans B L Hogervorst
  • Matti A Rookus
  • J Margriet Collee
  • Peter Devilee
  • Marjolijn J Ligtenberg
  • Rob B van der Luijt
  • Cora M Aalfs
  • Quinten Waisfisz
  • Juul Wijnen
  • Cornelis E P van Roozendaal
  • Susan Peock
  • Margaret Cook
  • Debra Frost
  • Clare Oliver
  • Radka Platte
  • D Gareth Evans
  • Fiona Lalloo
  • Rosalind Eeles
  • Louise Izatt
  • Rosemarie Davidson
  • Carol Chu
  • Diana Eccles
  • Trevor Cole
  • Shirley Hodgson
  • Andrew K Godwin
  • Dominique Stoppa-Lyonnet
  • Bruno Buecher
  • Mélanie Léoné
  • Brigitte Bressac-de Paillerets
  • Audrey Remenieras
  • Olivier Caron
  • Gilbert M Lenoir
  • Nicolas Sevenet
  • Michel Longy
  • Sandra Fert Ferrer
  • Fabienne Prieur
  • David Goldgar
  • Alexander Miron
  • Esther M John
  • Saundra S Buys
  • Mary B Daly
  • John L Hopper
  • Mary Beth Terry
  • Yosuf Yassin
  • Christian Singer
  • Daphne Gschwantler-Kaulich
  • Christine Staudigl
  • Thomas v O Hansen
  • Rosa Bjork Barkardottir
  • Tomas Kirchhoff
  • Prodipto Pal
  • Kristi Kosarin
  • Kenneth Offit
  • Marion Piedmonte
  • Gustavo C Rodriguez
  • Katie Wakeley
  • John F Boggess
  • Jack Basil
  • Peter E Schwartz
  • Stephanie V Blank
  • Amanda E Toland
  • Marco Montagna
  • Cinzia Casella
  • Evgeny N Imyanitov
  • Anna Allavena
  • Rita K Schmutzler
  • Beatrix Versmold
  • Christoph Engel
  • Alfons Meindl
  • Nina Ditsch
  • Norbert Arnold
  • Dieter Niederacher
  • Helmut Deissler
  • Britta Fiebig
  • Christian Suttner
  • Ines Schönbuchner
  • Dorothea Gadzicki
  • Trinidad Caldes
  • Miguel de la Hoya
  • Karen A Pooley
  • Douglas F Easton
  • Georgia Chenevix-Trench
چکیده

Genome-wide association studies of breast cancer have identified multiple single nucleotide polymorphisms (SNPs) that are associated with increased breast cancer risks in the general population. In a previous study, we demonstrated that the minor alleles at three of these SNPs, in FGFR2, TNRC9 and MAP3K1, also confer increased risks of breast cancer for BRCA1 or BRCA2 mutation carriers. Three additional SNPs rs3817198 at LSP1, rs13387042 at 2q35 and rs13281615 at 8q24 have since been reported to be associated with breast cancer in the general population, and in this study we evaluated their association with breast cancer risk in 9442 BRCA1 and 5665 BRCA2 mutation carriers from 33 study centres. The minor allele of rs3817198 was associated with increased breast cancer risk only for BRCA2 mutation carriers [hazard ratio (HR) = 1.16, 95% CI: 1.07-1.25, P-trend = 2.8 x 10(-4)]. The best fit for the association of SNP rs13387042 at 2q35 with breast cancer risk was a dominant model for both BRCA1 and BRCA2 mutation carriers (BRCA1: HR = 1.14, 95% CI: 1.04-1.25, P = 0.0047; BRCA2: HR = 1.18 95% CI: 1.04-1.33, P = 0.0079). SNP rs13281615 at 8q24 was not associated with breast cancer for either BRCA1 or BRCA2 mutation carriers, but the estimated association for BRCA2 mutation carriers (per-allele HR = 1.06, 95% CI: 0.98-1.14) was consistent with odds ratio estimates derived from population-based case-control studies. The LSP1 and 2q35 SNPs appear to interact multiplicatively on breast cancer risk for BRCA2 mutation carriers. There was no evidence that the associations vary by mutation type depending on whether the mutated protein is predicted to be stable or not.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

The known breast cancer susceptibility polymorphisms in FGFR2, TNRC9/TOX3, MAP3K1, LSP1, and 2q35 confer increased risks of breast cancer for BRCA1 or BRCA2 mutation carriers. We evaluated the associations of 3 additional single nucleotide polymorphisms (SNPs), rs4973768 in SLC4A7/NEK10, rs6504950 in STXBP4/COX11, and rs10941679 at 5p12, and reanalyzed the previous associations using additional...

متن کامل

Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers.

Germline mutations in BRCA1 and BRCA2 confer high risks of female breast and ovarian cancer. However, there is strong evidence that these risks are modified by other factors, including familial or genetic factors. Genome-wide association studies have identified several breast cancer genetic susceptibility variants in the general population that are also associated with breast cancer risk for mu...

متن کامل

Minor role of BRCA2 mutation (Exon2 and Exon11) in patients with early-onset breast cancer amongst Iranian Azeri-Turkish women

Objective(s): Breast cancer is the most common cancer in women. Every year, one million new cases are reported worldwide, representing 18% of the total number of cancer in women. Hereditary BRCA1 and BRCA2 mutations account for about 60% of inherited breast cancer and are the only known causes of hereditary breast cancer syndrome. The aim of this study was to determine the frequency of BRCA2 (e...

متن کامل

بررسی موتاسیون های شایع ژن BRCA1 و BRCA2 در دختران مادران مبتلا به سرطان سینه و مقایسه آن با گروه کنترل

Background and purpose: Breast Cancer is one of the health problems in every population. The aim of this study was to determine the frequency of BRCA1 and BRCA2 common mutations in women whose mothers were diagnosed with breast cancer. Materials and methods: A case–control study was performed in 109 females (less than 40 years of age) who had mothers with breast cancer. For scanning of...

متن کامل

Genetic susceptibility loci for breast cancer by estrogen receptor status.

Breast cancer is a heterogeneous disease, and risk factors could be differentially associated with the development of distinct tumor subtypes that manifest different biological behavior and progression. In support of this view, there is growing evidence that known breast cancer risk factors vary by hormone receptor status and perhaps other pathologic characteristics of disease. Recent work from...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Human molecular genetics

دوره 18 22  شماره 

صفحات  -

تاریخ انتشار 2009